xl092,atezolizumab,regorafenib
roche,bayer,exelixis
[]
at #gi23 we had the pleasure of speaking with of who gave us an overview of the stellar-303 trial evaluating xl092 in pretreated, mms/msi-low #colorectalcancer more on #gi23 #gism #gastrointestinalcancer #crc #crcsm 
The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm